{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:18:23Z","timestamp":1767831503691,"version":"3.49.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068227","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T21:13:30Z","timestamp":1373404410000},"page":"e68227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis"],"prefix":"10.1371","volume":"8","author":[{"given":"Wei","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Xi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Nin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.5858\/2006-130-1725-AILAKT","article-title":"An in-depth look at Krukenbergtumor: an overview","volume":"130","author":"OM Al-Agha","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"ref2","first-page":"476","article-title":"Gastric malignancy: resection for palliation","volume":"88","author":"GA Ekbom","year":"1980","journal-title":"Surgery"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1068-607X(98)00047-X","article-title":"Management of Krukenberg tumors: an 11-year experience and review of the literature","volume":"5","author":"F McGill","year":"1998","journal-title":"Prim Care Update Ob Gyns"},{"key":"ref4","first-page":"412","article-title":"Surgical treatment of Krukenbergtumours: case reports and clinical consideration","volume":"24","author":"L Chiavellati","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000010136","article-title":"Krukenberg tumors: can management be improved?","volume":"48","author":"FM McGill","year":"1999","journal-title":"GynecolObstet Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"A Ayhan","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/gyno.2001.6210","article-title":"Prognostic factors of Krukenberg\u2019stumor","volume":"82","author":"HK Kim","year":"2001","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1055-3207(03)00035-8","article-title":"Effective therapy for peritoneal dissemination in gastric cancer","volume":"12","author":"Y Yonemura","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5230\/jgc.2011.11.1.31","article-title":"Metachronous ovarian metastases following resection of the primary gastric cancer","volume":"11","author":"SY Jun","year":"2011","journal-title":"J Gastric Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.20072","article-title":"Surgical management and outcome of metachronousKrukenberg tumors from gastric cancer","volume":"87","author":"JH Cheong","year":"2004","journal-title":"J Surg Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1525-1438.2007.01078.x","article-title":"Prognostic factors for ovarian metastases from primary gastric cancer","volume":"18","author":"J Wang","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"JA Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5230\/jgc.2011.11.1.31","article-title":"Metachronous ovarian metastases following resection of the primary gastric cancer","volume":"11","author":"SY Jun","year":"2011","journal-title":"J Gastric Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12015-007-9002-0","article-title":"Stem cells and cancer: an overview","volume":"3","author":"KM Sales","year":"2007","journal-title":"Stem Cell Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"AB Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcb.23356","article-title":"Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line","volume":"113","author":"Z Xue","year":"2012","journal-title":"J Cell Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"S Takaishi","year":"2009","journal-title":"Stem Cells"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"MD Curley","year":"2009","journal-title":"Stem Cells"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","article-title":"Understanding the dual nature of CD44 in breast cancer progression","volume":"9","author":"JM Louderbough","year":"2011","journal-title":"Mol Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"J Yu","year":"2007","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","article-title":"Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells","volume":"3","author":"YC Chen","year":"2008","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/AKT signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"PL Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1432-0436.2006.00143.x","article-title":"MEK\/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal","volume":"75","author":"J Li","year":"2007","journal-title":"Differentiation"},{"key":"ref24","first-page":"682","article-title":"Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell","volume":"7","author":"RU Lukacs","year":"2010"},{"key":"ref25","first-page":"1888","article-title":"Tumor suppressor activity of CBX7 in lung carcinogenesis. Cell Cycle","volume":"11","author":"F Forzati","year":"2012"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2009.25.4706","article-title":"Multicenter phase III comparison of cisplatin\/S-1 with cisplatin\/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial","volume":"28","author":"JA Ajani","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"E Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"D Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"ref29","first-page":"687","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet","volume":"376","author":"YJ Bang","year":"2010"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kataoka Y, Okabe H, Yoshizawa A, Minamiguchi S, Yoshimura K, <etal>et al<\/etal>.. (2012) HER2 expression and its clinicopathological features in resectable gastric cancer. Gastric Cancer. Mar 14. [Epub ahead of print].","DOI":"10.1007\/s10120-012-0150-9"},{"key":"ref31","first-page":"278","article-title":"Ovarianmetastasesresection from extragenitalprimarysites: outcome and prognosticfactoranalysis of 147 patients. BMC Cancer","volume":"12","author":"W Li","year":"2012"},{"key":"ref32","first-page":"100","article-title":"CD133\/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer","volume":"99","author":"LM Smith","year":"2008"},{"key":"ref33","first-page":"2453","article-title":"Prognostic impact of CD133 expression in gastric carcinoma","volume":"30","author":"S Ishigami","year":"2010","journal-title":"Anticancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"K Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0959-437X(97)80147-5","article-title":"Sox genes find their feet","volume":"7","author":"LH Pevny","year":"1997","journal-title":"Genet Dev"},{"key":"ref36","first-page":"1233","article-title":"Oct3\/4 and sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma","volume":"29","author":"Q Wang","year":"2009","journal-title":"Anticancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1038\/sj.onc.1205088","article-title":"Human embryonic genes re-expressed in cancer cells","volume":"20","author":"M Monk","year":"2001","journal-title":"Oncogene"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-008-0676-8","article-title":"Activated AKT as an indicator of prognosis in gastric cancer","volume":"453","author":"C Cinti","year":"2008","journal-title":"Virchows Arch"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-9-40","article-title":"BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer","volume":"9","author":"XW Zhang","year":"2010","journal-title":"Mol Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1756-9966-29-114","article-title":"Oncogenic role of the chromobox protein CBX7 in gastric cancer","volume":"29","author":"XW Zhang","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1756-9966-29-143","article-title":"Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma","volume":"29","author":"YW Lu","year":"2010","journal-title":"J Exp Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:18:32Z","timestamp":1646007512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068227"}},"subtitle":[],"editor":[{"given":"Neil A.","family":"Bhowmick","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}